SBI Securities’s Plus Therapeutics PSTV Stock Holding History

SBI Securities’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1K	Buy	251 +145	+137%	+$791	﹤0.01%	2775
2026 Q1	$430	Buy	106 +32	+43%	+$243	﹤0.01%	2946
2025 Q4	$944	Sell	74 -60	-45%	-$905	﹤0.01%	2663
2025 Q3	$2.29K	Buy	134 +44	+49%	+$540	﹤0.01%	2368
2025 Q2	$785	Buy	90 +80	+800%	+$1.05K	﹤0.01%	2779
2025 Q1	$245	Buy	10 +7	+233%	+$196	﹤0.01%	3147
2024 Q4	$76	Buy	+3	New	+$96	﹤0.01%	3534

Other funds holding PSTV

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SBI Securities's PSTV Position: Q2 2026 in Review

SBI Securities increased its Plus Therapeutics (PSTV) stake by 137% in Q2 2026, buying an estimated $791 and bringing the position to 251 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2775.

SBI Securities first reported a position in PSTV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.29K in Q3 2025. 4 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

SBI Securities held 251 shares of Plus Therapeutics worth $1.1K as of Q2 2026.
SBI Securities bought 145 Plus Therapeutics shares in Q2 2026, an estimated $791.
Plus Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2775 holding.
SBI Securities first reported a position in Plus Therapeutics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Plus Therapeutics position peaked at $2.29K in Q3 2025.
4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.